IRIS

DE LAURENTIIS, MICHELINO

DE LAURENTIIS, MICHELINO  

DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 294 (tempo di esecuzione: 0.057 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
[Exemestane in the treatment of breast carcinoma: recent findings] 1.1 Articolo in rivista 2008 DE LAURENTIIS, Michelino; Carmen, Criscitiello; Agnese, Montanino; Claudette, Falato; Monica, Plaitano
Prognostic factors in human colorectal cancer. 1.1 Articolo in rivista 1997 A. R., Bianco; Carlomagno, Chiara; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; G., Tortora; F., Ciardiello
Targeted Therapy of Breast Cancer 8.01 Chairman di Sessioni di Convegni Internazionali 2009 DE LAURENTIIS, Michelino; Zielinski, C.
Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting protein kinase A. 1.1 Articolo in rivista 2000 Ciardiello, F; Caputo, R; Pomatico, G; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
Effect of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials 1.1 Articolo in rivista 2005 Abe, O; Abe, R; Carlomagno, Chiara; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino
Effect of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials 1.1 Articolo in rivista 2005 Abe, O; Abe, R; Carlomagno, Chiara; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino
Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part 1.5 Abstract in rivista 2007 G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino
Manuale di Oncologia Clinica 2.1 Contributo in volume (Capitolo o Saggio) 1996 Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo
C-erbB2 overexpression decreases the benefit of adiuvant tamoxifen in early breast cancer without axillary lymph node metastases. 1.1 Articolo in rivista 1996 Carlomagno, Chiara; Perrone, F.; Gallo, C.; DE LAURENTIIS, Michelino; Lauria, R.; Morabito, A.; Pettinato, G.; Bianco, A. R.; DE PLACIDO, Sabino
A Feasibilty Study of a Sequential Dose-Dense Adjuvant Regimen with Epidoxorubicin Followed by Docetaxel Followed by High-Dose Cyclophosphamide for Early Breast Cancer with 4 or More Lymph Node Metastases. 4.1 Articoli in Atti di convegno 2001 Francesco, Cognetti; Arpino, Grazia; DE LAURENTIIS, Michelino; Paola, Papaldo; Chiara, Sguotti; Modesto, D'Aprile; Francesco, Recchia; DE PLACIDO, Sabino; Angelo Raffaele, Bianco
Lapatinib in breast cancer: clinical experiences and future perspectives. 1.1 Articolo in rivista 2010 Giampaglia, M; Chiuri, Ve; Tinelli, A; DE LAURENTIIS, Michelino; Silvestris, N; Lorusso, V.
A Metanalysis on the Interaction between HER2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer 1.1 Articolo in rivista 2005 DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, E; Ruggiero, A; Carlomagno, Chiara; Ciardiello, F; Tortora, G; D’Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, R; Bianco, Ar; DE PLACIDO, Sabino
Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncology. 1.1 Articolo in rivista 2005 DE LAURENTIIS, Michelino; Cancello, G; Zinno, L; Montagna, E; Malorni, L; Esposito, A; Pennacchio, R; Silvestro, L; Giuliano, Mario; Giordano, A; Caputo, F; Accurso, A; DE PLACIDO, Sabino
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study). 1.1 Articolo in rivista 1995 DE PLACIDO, Sabino; F., Perrone; Carlomagno, Chiara; A., Morabito; Pagliarulo, Clorindo; Lauria, Rossella; Marinelli, Alfredo; DE LAURENTIIS, Michelino; E., Varriale; Petrella, Giuseppe
Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer. 1.1 Articolo in rivista 1993 A. R., Bianco; DE PLACIDO, Sabino; F., Perrone; Carlomagno, Chiara; DE LAURENTIIS, Michelino; L., Del Mastro; R., Lauria; Marinelli, Alfredo; C., Gallo
Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease. 1.1 Articolo in rivista 2003 DI LORENZO, Giuseppe; Autorino, Riccardo; DE LAURENTIIS, Michelino; Bianco, Roberto; Lauria, Rossella; Giordano, A; De Sio, M; D'Armiento, Massimino; Bianco, Ar; DE PLACIDO, Sabino
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. 1.1 Articolo in rivista 2010 Correa, C; Mcgale, P; Taylor, C; Wang, Y; Clarke, M; Davies, C; Peto, R; Bijker, N; Solin, L; Darby, S; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; Carlomagno, Chiara; DE PLACIDO, Sabino
HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies 1.5 Abstract in rivista 2002 DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; A., Ruggiero; Carlomagno, Chiara; G., Tortora; F., Ciardiello; Ar, Bianco
Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. 1.1 Articolo in rivista 1994 P. M., Ravdin; DE LAURENTIIS, Michelino; T., Vendely; G. M., Clark
Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer? 1.1 Articolo in rivista 1994 C. L., Loprinzi; P. M., Ravdin; DE LAURENTIIS, Michelino; P., Novotny